New study examines the potential value proposition of retail clinics
27 April 2015
Retail health clinics are now a part of the health care landscape with the potential to become a much more powerful enabler of a “culture of health,” according to a recent report by Manatt Health, the health care division of Manatt, Phelps & Phillips.
China steps up decentralized drug industry regulation, market prices push
27 April 2015
China authorities at the highest level are acting on legislation that would, among other things, decentralize drug industry regulation and free some price controls.
Device companies team up to launch Asia Pacific Medical Technology Association in Singapore
27 April 2015
Industry bigwigs are teaming up to create the first medical device industry association focused solely on Asia. The member companies of the just-launched Asia Pacific Medical Technology Association (APACMed) include Abbott, Baxter, B. Braun, Becton Dickinson, Boston Scientific, Cardinal Health, GE Healthcar, Johnson & Johnson, Medtronic, Philips, Siemens, Stryker and Zimmer.
Marinus Pharmaceuticals insider Gail M. Farfel Sells 30,000 Shares (MRNS)
24 April 2015
Marinus Pharmaceuticals (NASDAQ:MRNS) insider Gail M. Farfel sold 30,000 shares of Marinus Pharmaceuticals stock on the open market in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $9.48, for a total value of $284,400.00.
Hydrogel Corneal Inlay Promising in Pseudophakic Presbyopia
24 April 2015
A transparent hydrogel corneal inlay is a novel way to correct the vision of patients with pseudophakic presbyopia, a new study shows.
It pays to seek EMA advice, analysis shows; the earlier, the better
24 April 2015
Taking the EMA's advice on trial design is both voluntary and costly, but a new analysis shows that doing so vastly increases the likelihood of getting marketing approval.
Watch out, Big Pharma: A Teva-Mylan combo would remake the industry Top 10
24 April 2015
As of 2014, Teva ($TEVA) is in the No. 11 spot on the list of pharma's top revenue generators. But if it gets its way and lands a deal for rival generics maker Mylan ($MYL), just how much will it be moving up the charts?
Small European study highlights promise of gene therapy for rare immune disease
24 April 2015
A biotech with deep roots in the European gene therapy field has successfully tested a new approach to creating a personalized gene therapy for a rare disorder of the immune system.
FDA issues new guidelines on acceptance of data from overseas clinical trials
23 April 2015
The FDA issued guidelines on its acceptance of medical device clinical data from overseas studies in a just-issued draft guidance, saying the "increasing globalization of clinical trials presents challenges to both U.S. and foreign regulators."
FDA, industry scrambling to clarify or design new regs covering lab-developed tests
23 April 2015
Science is rapidly shaping the landscape of the diagnostics industry, from the research into genetics and new materials like graphene, to the regulatory science practiced at the FDA.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024